Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
FOX21 Colorado Springs· 1 day agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 14 hours agoAs part of the changes, the company also unveiled a new logo. Last year, GSK rebranded as it...
Women need not fear menopause hormone drugs, major health study finds
Anchorage Daily News· 14 hours agoMore than two decades ago, the shocking results of a major women’s health study challenged the...
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 15 hours agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
Repare Therapeutics appoints new board member By Investing.com
Investing.com· 5 days agoDr. Stein's inclusion comes as Repare continues to expand its pipeline of cancer treatments. With a...
Scientists Can Now See Inside a Single Cancer Cell
Gizmodo via Yahoo News· 6 days agoA team in the UK hasfound a new window into cancer, thanks to a novel imaging technique that allows them to take a detailed look at the fatty cargo...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 19 hours ago, opens new tab raised its full-year profit forecast on Wednesday on strong demand for its common...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition - WTOP News
WTOP Washington· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...
These Are the Drugs America Is Running Short On
247wallst.com· 3 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
US Challenges 'Bogus' Patents on Ozempic and Other Drugs in Effort to Spur Competition
US News & World Report· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...